General issues related to patents and access to generics/biosimilars.
2026 · 2nd Quarter (Apr 1 - June 30)
ASSOCIATION FOR ACCESSIBLE MEDICINES
Filed by FEROX STRATEGIES.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- FEROX STRATEGIES
- Filing UUID
- c4168582-36e5-437a-ba5d-c254e2e67d2b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
General issues related to treatment access.
General issues related to generic development and commercialization.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.